Evidence map›Paper›PMID 37754881›Full record

ArticleJournal of functional biomaterials2023

Characterization and Evaluation of Silver Concentrations in Hydroxyapatite Powders.

Néstor Méndez-Lozano, Miguel Apatiga-Castro, Alvaro de Jesús Ruíz-Baltazar, Miguel de la Luz-Asunción, Eduardo E Pérez-Ramírez

Abstract read
In one paragraph

Article in Journal of functional biomaterials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Néstor Méndez-LozanoCampus Querétaro, Universidad del Valle de México, Blvd. Juriquilla No. 1000 A Del., Santa Rosa Jáuregui 76230, Querétaro, Mexico.ORCID 0000-0001-5622-9283
Miguel Apatiga-CastroCONAHCYT-Centro de Física Aplicada y Tecnología Avanzada, Universidad Nacional Autónoma de México, Boulevard Juriquilla 3001, Santiago de Querétaro 76230, Querétaro, Mexico.
Alvaro de Jesús Ruíz-BaltazarCONAHCYT-Centro de Física Aplicada y Tecnología Avanzada, Universidad Nacional Autónoma de México, Boulevard Juriquilla 3001, Santiago de Querétaro 76230, Querétaro, Mexico.ORCID 0000-0003-1032-3279
Miguel de la Luz-AsunciónCampus Querétaro, Universidad del Valle de México, Blvd. Juriquilla No. 1000 A Del., Santa Rosa Jáuregui 76230, Querétaro, Mexico.
Eduardo E Pérez-RamírezCampus Querétaro, Universidad del Valle de México, Blvd. Juriquilla No. 1000 A Del., Santa Rosa Jáuregui 76230, Querétaro, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The goal of this study is to evaluate the influence of the concentration of silver on the structural and antimicrobial in vitro properties of silver-doped hydroxyapatite powders obtained using the precipitation method. Different concentrations of silver were evaluated to assess the antimicrobial properties. X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), Raman spectroscopy, scanning electron microscopy (SEM), and dispersive energy spectroscopy (EDS) were used to characterize the powders. XRD and FTIR showed that the hydroxyapatite structure is not affected by the incorporation of silver; on the other hand, EDS showed the presence of silver in the powders. Antibacterial studies showed the efficiency of hydroxyapatite powders in inhibiting bacterial growth as silver concentration increases. According to the results, silver-doped hydroxyapatite powders are suggested for use in the prevention and treatment of infections in bone and dental tissues.

Indexed as

antibacterial evaluationbiomedical applicationscrystalline structurehydroxyapatite powders

Identifiers

PMID37754881
PMCPMC10532154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.